Von Meyenburg complex is a benign biliary hamartoma observed in approximately 3% of the autopsies conducted. These hamartomas are small, multiple and can be seen anywhere in the liver. There is usually no abnormality in liver function tests, and the patient is mostly asymptomatic. They serve as a diagnostic dilemma, particularly during metastatic workup in suspected cancer patients. Imaging studies are usually noncontributory, and biopsy is necessary for a definite diagnosis. We present here a middle-aged North Indian male who underwent liver biopsy to rule out metastasis.
three cells were karyotype A (45,X,-Y), 13 cells were karyotype B (45, idem, t(10;18)(q26;q21), and four cells were karyotype C (46, XY) [ Figure 1C ]. The patient was diagnosed with MDS-U. The patient remains carefully observed in our hospital as an outpatient thereafter.
Discussion
We recently reported the usefulness of careful histogram analysis of automatic blood cell analyzer results for acute leukemia, which assists with rapid morphological findings for blasts and abnormal cells. [3] However, not only morphologic but also cytogenetic studies are necessary to diagnose hematologic malignancies; this is common knowledge for clinical hematologists. A unique feature of the present case may be that the bone marrow aspiration and chromosome analysis were ordered and performed by cardiovascular surgeons rather than hematologists during the aortic valvuloplasty and coronary artery bypass graft surgery.
We speculate that the most likely gene playing a role in the pathogenesis of this patient's disease is BCL2. The BCL2 gene lies within 18q21.3 and is frequently translocated to the immunoglobulin heavy chain (IgH) gene enhancer region as a result of t(14;18)(q32;q21.3), which results in the over-expression of the BCL2 gene. [4] BCL2 overexpression is involved in the pathogenesis of follicular lymphoma by preventing apoptosis of the germinal center B-cells. [4] The t(14;18)(q32;q21.3) translocation can be detected by fluorescence in situ hybridization in 85% of all cases and is considered a molecular hallmark of this disease.
Not only follicular lymphoma but also several other hematopoietic malignancies are reported to be related to the aberrant expression of the BCL2 protein. [5] In particular, in MDS patients, BCL2 expression is high, while in aplastic anemia patients, BCL2 expression is low. [5] Previously, it was reported that progression to high-risk MDS correlates with elevated expression of BCL2 protein. [6] Collectively, BCL2 expression and regulation may affect the pathophysiology of MDS. Chromosome 10 and 18 translocations are very rare. To the best of our knowledge, only four studies have reported such translocations. [7] [8] [9] [10] In particular, the breakpoint we observed, t(10;18)(q26;q21), was unique because it is not among these reported translocations. Although we could not identify what was fused with the gene residing in 18q21.3 (possibly the BCL2 gene), since this patient is too stable to perform further analysis, these results indicate that characterizing the gene (s) affected by this rare translocation may lead to further understanding of the biology of MDS.
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Introduction
V on Meyenburg complex (VMC) is a benign developmental ductal plate malformation of the intrahepatic bile duct. The condition is asymptomatic and leads to hamartomatous proliferation of bile ducts anywhere along the hepatic tree. VMC has been described as early in 1918. [1] These hamartomas are usually smaller than 5 mm, and hence radiological detection is seen in <1% of cases. Its incidence based on autopsy studies is approximately 5.6% in adults and 0.9% in children. There is no particular sex predilection. [2] The clinical differential diagnosis includes metastasis, microabscesses, simple liver cysts, etc., Even though VMC is benign and asymptomatic, the possibility of progressing to cholangiocarcinoma is a serious concern and these patients should be kept in follow-up. [3] The case merits publication because of rarity of diagnosis and it being seen in a male in later years of life.
Case Report
A 65-year-old North Indian male presented with yellowish discoloration of sclera, weakness, abdominal pain, and recurrent vomiting, particularly after meals for 1 month. On examination, a vague, firm-to-hard lump was felt in the right hypochondrium. His total serum bilirubin was 2.1 mg/dl (direct: 0.8 mg/dl and indirect: 1.3 mg/dl). Alkaline phosphatase was almost four times elevated (367 IU/L). Albumin was low; 3 g/dl and A:G ratio was reversed (0.79:1). Prothrombin time and international normalized ratio were however within the normal limits. He had moderate anemia (8.5 g/dl) macrocytic type with few target cells on peripheral blood smear. HIV, hepatitis B surface antigen, and hepatitis C virus were nonreactive. Ultrasound of the abdomen showed nodular liver with occasional space-occupying lesions and few small cysts [ Figure 1 ]. A clinical impression of neoplasia favoring metastasis was made, and ultrasound-guided fine-needle aspiration cytology was performed. The lesion was exhibiting low cellularity with a variable amount of fibrous fragments in the This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
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background. A possibility of vascular lesion was rendered, and biopsy was advised. The Tru-cut liver biopsy using Menghinis needle was fragmented. There was partial effacement of lobular architecture [ Figure 2 ]. A large number of proliferating bile ducts were seen lined by the single layer of uniform cuboidal epithelium showing no mitotic activity [Figures 3 and 4 ]. Mild-to-moderate fibrosis was seen around these ductules as demonstrated by special stains [ Figure 5 ]. A diagnosis of bile duct hamartoma or VMC was rendered on histopathology. The rest of the metastatic workup were unremarkable. There were no other systemic anomalies or renal cysts, and alpha-fetoprotein levels were within the normal limits. The patient was discharged after 2 units of packed red blood cell and 2 units of fresh frozen plasma infusion. He is presently asymptomatic and is attending follow-up clinic.
Discussion
VMC or biliary microhamartomas are multiple, small (<1.5 cm), cystic, multinodular lesions in the liver affecting the small intrahepatic bile ducts as a result of atypical embryonic development. [4] VMC does not usually cause altered liver function tests and is mostly asymptomatic clinically. The disease is named after a Dresden born pathologist von Meyenburg, who first described this entity in 1918. [1] Hence, biliary hamartomas are also known as "von Meyenburg complexes." Biliary hamartomas are composed of small, haphazardly distributed aggregates of cystically dilated bile ducts lined by a single uniform layer of cuboidal cells and surrounded by fibrocollagenous stroma. They may or may not communicate with the biliary tree and are thought to arise from embryonic bile duct remnants that have failed to involute. [5] VMC is seen to coexist with other cystic diseases such as polycystic liver disease and autosomal polycystic kidney disease. [6] Possible malignant transformation documented is into hepatocellular carcinoma and cholangiocarcinoma. This malignant transformation has been attributed to the presence of bile (stasis) and prolonged exposure to carcinogens. [3] Radiologically, they are seen as multiple small round or irregular lesions throughout the liver, particularly seen 
